IDH2 and myelodysplastic syndrome: IDH mutations were first reported in a metastatic colon cancer in 2006 [29], and then since 2010 recurring IDH mutations were successively found in MDS (3.42%∼12.27%) [3], [14], [17], [30], [31], [32].